Clinical trials sponsored by Institute of Hematology & Blood Diseases Hospital, China

Phase breakdown

Conditions studied

Recruiting trials led by Institute of Hematology & Blood Diseases Hospital, China

• CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
  NCT06941129 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
  NCT07315087 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients
  NCT06880380 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Institute of Hematology & Blood Diseases Hospital, China recruiting for?

Institute of Hematology & Blood Diseases Hospital, China is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.